These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30048127)

  • 1. Host Cell Protein Profiling in Biopharmaceutical Harvests.
    Obrstar D; Kröner F; Japelj B; Bojic L; Anderka O
    Anal Chem; 2018 Oct; 90(19):11240-11247. PubMed ID: 30048127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling of host cell proteins by two-dimensional difference gel electrophoresis (2D-DIGE): Implications for downstream process development.
    Jin M; Szapiel N; Zhang J; Hickey J; Ghose S
    Biotechnol Bioeng; 2010 Feb; 105(2):306-16. PubMed ID: 19739084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More similar than different: Host cell protein production using three null CHO cell lines.
    Yuk IH; Nishihara J; Walker D; Huang E; Gunawan F; Subramanian J; Pynn AF; Yu XC; Zhu-Shimoni J; Vanderlaan M; Krawitz DC
    Biotechnol Bioeng; 2015 Oct; 112(10):2068-83. PubMed ID: 25894672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass spectrometric evaluation of upstream and downstream process influences on host cell protein patterns in biopharmaceutical products.
    Falkenberg H; Waldera-Lupa DM; Vanderlaan M; Schwab T; Krapfenbauer K; Studts JM; Flad T; Waerner T
    Biotechnol Prog; 2019 May; 35(3):e2788. PubMed ID: 30767403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of co-purifying CHO host cell proteins in monoclonal antibody purification process.
    Liu X; Chen Y; Zhao Y; Liu-Compton V; Chen W; Payne G; Lazar AC
    J Pharm Biomed Anal; 2019 Sep; 174():500-508. PubMed ID: 31234041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of platform host cell protein ELISA to process-specific host cell protein ELISA.
    Gunawan F; Nishihara J; Liu P; Sandoval W; Vanderlaan M; Zhang H; Krawitz D
    Biotechnol Bioeng; 2018 Feb; 115(2):382-389. PubMed ID: 28986978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of difficult-to-remove host cell protein impurities during extended Chinese hamster ovary cell culture and their impact on continuous bioprocessing.
    Valente KN; Lenhoff AM; Lee KH
    Biotechnol Bioeng; 2015 Jun; 112(6):1232-42. PubMed ID: 25502542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a host cell protein impurity in therapeutic protein, P1.
    Ahluwalia D; Dhillon H; Slaney T; Song H; Boux H; Mehta S; Zhang L; Valdez A; Krishnamurthy G
    J Pharm Biomed Anal; 2017 Jul; 141():32-38. PubMed ID: 28419935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild hypothermic culture conditions affect residual host cell protein composition post-Protein A chromatography.
    Goey CH; Bell D; Kontoravdi C
    MAbs; 2018 Apr; 10(3):476-487. PubMed ID: 29381421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host cell protein testing by ELISAs and the use of orthogonal methods.
    Zhu-Shimoni J; Yu C; Nishihara J; Wong RM; Gunawan F; Lin M; Krawitz D; Liu P; Sandoval W; Vanderlaan M
    Biotechnol Bioeng; 2014 Dec; 111(12):2367-79. PubMed ID: 24995961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of robust host cell protein clearance in biopharmaceutical downstream processes.
    Shukla AA; Jiang C; Ma J; Rubacha M; Flansburg L; Lee SS
    Biotechnol Prog; 2008; 24(3):615-22. PubMed ID: 18410156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with host cell protein impurities in biopharmaceuticals.
    Vanderlaan M; Zhu-Shimoni J; Lin S; Gunawan F; Waerner T; Van Cott KE
    Biotechnol Prog; 2018 Jul; 34(4):828-837. PubMed ID: 29693803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-house CHO HCPs platform: A promising approach for HCPs ELISA monitoring.
    Giordano E; Liori B; Cecchini I; Verani R; Leone L
    Eur J Pharm Sci; 2024 Jan; 192():106656. PubMed ID: 38029932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of proteomic methods for CHO host cell protein characterization in biopharmaceutical manufacturing.
    Valente KN; Levy NE; Lee KH; Lenhoff AM
    Curr Opin Biotechnol; 2018 Oct; 53():144-150. PubMed ID: 29414072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host cell protein dynamics in the supernatant of a mAb producing CHO cell line.
    Tait AS; Hogwood CE; Smales CM; Bracewell DG
    Biotechnol Bioeng; 2012 Apr; 109(4):971-82. PubMed ID: 22124969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymer-mediated flocculation of transient CHO cultures as a simple, high throughput method to facilitate antibody discovery.
    Schmitt MG; Rajendra Y; Hougland MD; Boyles JS; Barnard GC
    Biotechnol Prog; 2017 Sep; 33(5):1393-1400. PubMed ID: 28722325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of Chinese hamster ovary host cell proteins for proteomic analysis.
    Valente KN; Schaefer AK; Kempton HR; Lenhoff AM; Lee KH
    Biotechnol J; 2014 Jan; 9(1):87-99. PubMed ID: 24039059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of CHO host-cell proteins in monoclonal antibody bioprocessing.
    Oh YH; Mendola KM; Choe LH; Min L; Lavoie AR; Sripada SA; Williams TI; Lee KH; Yigzaw Y; Seay A; Bill J; Li X; Roush DJ; Cramer SM; Menegatti S; Lenhoff AM
    Biotechnol Bioeng; 2024 Jan; 121(1):291-305. PubMed ID: 37877536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxa2- and Ctsd-knockout CHO cell lines to diminish the risk of contamination with host cell proteins.
    Fukuda N; Senga Y; Honda S
    Biotechnol Prog; 2019 Jul; 35(4):e2820. PubMed ID: 30972970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-D Western blotting for evaluation of antibodies developed for detection of host cell protein.
    Berkelman T; Harbers A; Bandhakavi S
    Methods Mol Biol; 2015; 1295():393-414. PubMed ID: 25820736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.